Related Experiment Videos
[Disordered hormone regulation in gynecomastia].
1Berufsgenossenschaftliche Kliniken Bergmannsheil, Universitätsklinik, Medizinische Klinik und Poliklinik, Bürkle-de-la-Camp-Platz 1, 44789 Bochum. Johannes.Pfeilschifter@ruhr-uni-bochum.de
Kongressband. Deutsche Gesellschaft Fur Chirurgie. Kongress
|April 23, 2003
Summary
Gynecomastia, or male breast enlargement, occurs when estrogen levels rise relative to androgens. Significant or painful gynecomastia warrants medical evaluation for underlying conditions.
Area of Science:
- Endocrinology
- Oncology
- Nephrology
- Hepatology
Context:
- Gynecomastia is a common condition in males, often benign.
- Significant, painful, or rapidly progressing gynecomastia necessitates thorough medical investigation.
- It can be an indicator of underlying systemic diseases.
Purpose:
- To outline the causes and diagnostic evaluation of gynecomastia.
- To emphasize the importance of evaluating concerning presentations of gynecomastia.
Summary:
- Gynecomastia results from an elevated estrogen-to-androgen ratio.
- Potential causes include medications, hormonal imbalances, tumors, and systemic illnesses like kidney failure, liver cirrhosis, and thyrotoxicosis.
- Diagnostic steps involve patient history, physical examination, and laboratory tests including hormone levels (LH, FSH, testosterone, estradiol, hCG-beta, TSH) and organ function tests.
Impact:
- Highlights the differential diagnosis of gynecomastia.
- Guides clinicians in evaluating patients with breast enlargement.
- Underscores the potential for gynecomastia to signal serious underlying pathology.